Epilepsy Devices Market

Epilepsy Devices Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 334

To learn more about this report, request a free sample copy

Epilepsy Devices Market Overview

The report is titled as ‘Epilepsy Devices Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the epilepsy devices market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The epilepsy devices market is expected to grow at a significant rate in the near future.

The global epilepsy devices market was valued US$ 7.5 Bn at the end of 2020 and expected to reach at a value of US$ 13.7 Bn by 2028 with a significant CAGR of 7.9%.

Epilepsy Devices Introduction

Epilepsy can be perceived as a chronic medical condition. Basically, it is a neurological disorder which usually causes frequent unjustifiable seizures, characterized by obscure events of spontaneous movement comprising either a partial part of the body or the entire body. On the other hand, the primary reason for epilepsy is yet unidentified. Some individuals may develop harmful diseases like epilepsy in the wake of strokes, trauma, brain tumors, infections, and birth problems. As per the World Health Organization (WHO), roughly 50 million of the global population is at present affected by epilepsy making it one of the most widely spread neurological disorders across the world.

The medical diagnosis of epilepsy is made through blood tests which comprises the entire blood count, electroencephalograms (EEG), computerized tomography scanning (CT), and magnetic resonance imaging (MRI) in response to the epilepsy symptoms. In addition to that, the numerous therapeutic devices offer new alternatives for the treatment of epilepsy.

Epilepsy Devices Market Dynamics

The massively rising prevalence of epilepsy among the population, especially in geriatric population, across the world is primarily boosting the growth of the global epilepsy devices market. By the same token, the most common cause of epilepsy among the aged masses is the increasing incidence of stroke-related or cryptogenic seizure, followed by tumors and dementia. Owing to which, the epilepsy devices market is projected to grow higher in the years to come.

On top of that, the growing number of technological advancements in the medical devices, therapeutics as well as in the entire healthcare sector, worldwide, is also playing a major role in propelling the growth of the global epilepsy devices market in the near future. In addition to that, the growing degree of awareness among the population regarding the disease and the associated medical devices and treatment process is also positively fueling the growth of the global epilepsy devices market in the forthcoming future.

However, the diagnosis and medical treatment of diseases like epilepsy might cost higher which is likely to hold back the growth of the global epilepsy devices market over the forecast period. Nevertheless, the rising funding for the research and development activities in epilepsy is yet expected to boost the growth of the global epilepsy devices market in the coming years.

Epilepsy Devices Market Segmentation

The global epilepsy devices market is segmented on the basis of product type, end-user, and region. The product type segment of the epilepsy devices market is divided into Vagus Nerve Stimulator, Responsive Neurostimulation. Furthermore, the end-user segment is divided into Hospitals & Clinics, Ambulatory Surgical Centers, Neurology Centers, Homecare Settings, Others.

Epilepsy Devices Market Key Players

The global epilepsy devices market is dominated by Cerbomed GmbH, electroCore, Inc., Cyberonics, Inc., NeuroPace, Inc., Boston Scientific Corporation, Medtronic plc,, among others.

MMC Overview on Epilepsy Devices Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the epilepsy devices market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of epilepsy devices

Advantages of epilepsy devices

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Epilepsy Devices Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Epilepsy Devices Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Epilepsy Devices Market Snapshot

2.4.    Global Epilepsy Devices Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Epilepsy Devices Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Porter’s Five Forces Model

2.7.    SWOT Analysis

3.    Epilepsy Devices Assessment and Analysis

3.1.    Epilepsy Devices Impact Analysis 

3.2.    Actions to encourage use of Epilepsy Devices

3.3.    Epilepsy Devices Promotional Strategy Recommendation

3.4.    Road Map Analysis

3.5.    GAP Analysis

3.6.    Potential Analysis

4.    Covid-19 Impact on Epilepsy Devices Market

5.    Global Epilepsy Devices Market, By Product Type

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Product Type

5.1.2.    BPS Analysis, By Product Type

5.2.    Market Revenue (US$ Mn) and Forecast, By Product Type

5.2.1.    Vagus Nerve Stimulator

5.2.2.    Responsive Neurostimulation 

5.3.    Global Epilepsy Devices Market Attractiveness Index, By Product Type

6.    Global Epilepsy Devices Market, By End-Users

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By End-Users

6.1.2.    BPS Analysis, By End-Users

6.2.    Market Revenue (US$ Mn) and Forecast, By End-Users

6.2.1.    Hospitals & Clinics

6.2.2.    Ambulatory Surgical Centers

6.2.3.    Neurology Centers

6.2.4.    Homecare Settings

6.2.5.    Others

6.3.    Global Epilepsy Devices Market Attractiveness Index, By End-Users

7.    Global Epilepsy Devices Market, By Region

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Region

7.1.2.    BPS Analysis, By Region

7.2.    Market Revenue (US$ Mn) and Forecast, By Region

7.2.1.    North America

7.2.2.    Latin America

7.2.3.    Europe

7.2.4.    Asia Pacific

7.2.5.    Middle East 

7.2.6.    Africa

7.3.    Global Epilepsy Devices Market Attractiveness Index, By Region

8.    North America Epilepsy Devices Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$ Mn) and Forecast, By Country

8.2.1.    U.S. Epilepsy Devices Market

8.2.2.    Canada Epilepsy Devices Market

8.3.    North America Epilepsy Devices Market, By Product Type

8.3.1.    Vagus Nerve Stimulator

8.3.2.    Responsive Neurostimulator

8.4.    North America Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users

8.4.1.    Hospitals & Clinics

8.4.2.    Ambulatory Surgical Centers

8.4.3.    Neurology Centers

8.4.4.    Homecare Settings

8.4.5.    Others

8.5.    North America Epilepsy Devices Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Product Type

8.5.3.    By End-Users

9.    Latin America Epilepsy Devices Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$ Mn) Forecast, By Country

9.2.1.    Brazil Epilepsy Devices Market

9.2.2.    Mexico Epilepsy Devices Market

9.2.3.    Rest of Latin America Epilepsy Devices Market

9.3.    Latin America Epilepsy Devices Market, By Product Type

9.3.1.    Vagus Nerve Stimulator

9.3.2.    Responsive Neurostimulator

9.4.    Latin America Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users

9.4.1.    Hospitals & Clinics

9.4.2.    Ambulatory Surgical Centers

9.4.3.    Neurology Centers

9.4.4.    Homecare Settings

9.4.5.    Others

9.5.    Latin America Epilepsy Devices Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Product Type

9.5.3.    By End-Users

10.    Europe Epilepsy Devices Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$ Mn) Forecast, By Country

10.2.1.    U.K. Epilepsy Devices Market

10.2.2.    Germany Epilepsy Devices Market

10.2.3.    Italy Epilepsy Devices Market

10.2.4.    France Epilepsy Devices Market

10.2.5.    Spain Epilepsy Devices Market

10.2.6.    Russia Epilepsy Devices Market

10.2.7.    Rest of Europe Epilepsy Devices Market

10.3.    Europe Epilepsy Devices Market, By Product Type

10.3.1.    Vagus Nerve Stimulator

10.3.2.    Responsive Neurostimulator

10.4.    Europe Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users

10.4.1.    Hospitals & Clinics

10.4.2.    Ambulatory Surgical Centers

10.4.3.    Neurology Centers

10.4.4.    Homecare Settings

10.4.5.    Others

10.5.    Europe Epilepsy Devices Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Product Type

10.5.3.    By End-Users

11.    Asia Pacific Epilepsy Devices Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$ Mn) Forecast, By Country

11.2.1.    China Epilepsy Devices Market

11.2.2.    India Epilepsy Devices Market

11.2.3.    Japan Epilepsy Devices Market

11.2.4.    Australia and New Zealand Epilepsy Devices Market

11.2.5.    South Korea Epilepsy Devices Market

11.2.6.    Rest of Asia Pacific Epilepsy Devices Market

11.3.    Asia Pacific Epilepsy Devices Market, By Product Type

11.3.1.    Vagus Nerve Stimulator

11.3.2.    Responsive Neurostimulator

11.4.    Asia Pacific Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users

11.4.1.    Hospitals & Clinics

11.4.2.    Ambulatory Surgical Centers

11.4.3.    Neurology Centers

11.4.4.    Homecare Settings

11.4.5.    Others

11.5.    Asia Pacific Epilepsy Devices Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Product Type

11.5.3.    By End-Users

12.    Middle East Epilepsy Devices Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$ Mn) Forecast, By Country

12.2.1.    GCC Countries Epilepsy Devices Market

12.2.2.    Israel Epilepsy Devices Market

12.2.3.    Rest of Middle East Epilepsy Devices Market

12.3.    Middle East Epilepsy Devices Market, By Product Type

12.3.1.    Vagus Nerve Stimulator

12.3.2.    Responsive Neurostimulator

12.4.    Middle East Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users

12.4.1.    Hospitals & Clinics

12.4.2.    Ambulatory Surgical Centers

12.4.3.    Neurology Centers

12.4.4.    Homecare Settings

12.4.5.    Others

12.5.    Middle East Epilepsy Devices Market Attractiveness Index

12.5.1.    By Country

12.5.2.    By Product Type

12.5.3.    By End-Users

13.    Africa Epilepsy Devices Market Analysis and Forecast, 2020–2028

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$ Mn) Forecast, By Country

13.2.1.    South Africa Countries Epilepsy Devices Market

13.2.2.    Egypt Epilepsy Devices Market

13.2.3.    North Africa Epilepsy Devices Market

13.2.4.    Rest of Africa Epilepsy Devices Market

13.3.    Africa Epilepsy Devices Market, By Product Type

13.3.1.    Vagus Nerve Stimulator

13.3.2.    Responsive Neurostimulator

13.4.    Africa Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users

13.4.1.    Hospitals & Clinics

13.4.2.    Ambulatory Surgical Centers

13.4.3.    Neurology Centers

13.4.4.    Homecare Settings

13.4.5.    Others

13.5.    Africa Epilepsy Devices Market Attractiveness Index

13.5.1.    By Country

13.5.2.    By Product Type

13.5.3.    By End-Users

14.    Competitive Landscape

14.1.    Company Profiles

14.1.1.    Cerbomed GmbH

14.1.1.1.    Company Overview

14.1.1.2.    Financial Overview

14.1.1.3.    Key Developments

14.1.1.4.    Strategies

14.1.1.5.    Product Portfolio

14.1.2.    electroCore Inc.

14.1.3.    Cyberonics Inc.

14.1.4.    NeuroPace Inc.

14.1.5.    Boston Scientific Corporation

14.1.6.    Medtronic plc.

15.    Acronyms

Select License Type

Frequently Asked Questions

The global epilepsy devices market was valued US$ 7.5 Bn at the end of 2020 and expected to reach at a value of US$ 13.7 Bn by 2028 with a significant CAGR of 7.9%

The massively rising prevalence of epilepsy among the population, especially in geriatric population, growing number of technological advancements in the medical devices, therapeutics as well as in the entire healthcare sector, worldwide are the key factors driving the growth of market

The global epilepsy devices market is segmented on the basis of product type, end-user, and region

Cerbomed GmbH, electroCore, Inc., Cyberonics, Inc., NeuroPace, Inc., Boston Scientific Corporation, Medtronic plc,, among others are the key participating players in the market



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK